Paget's disease of scrotum and penis case report of a re-irradiation and review of the literature.
extramammary Paget
radiotherapy
re-irradiation
scrotum
skin
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
01
06
2020
accepted:
21
06
2020
pubmed:
26
6
2020
medline:
15
5
2021
entrez:
26
6
2020
Statut:
ppublish
Résumé
Extramammary Paget's disease (EMPD) is a rare cutaneous adenocarcinoma generally arising in the anogenital region. Surgery is still considered the treatment of choice for patients with EMPD, while Radiotherapy is a common alternative for inoperable cases and it's necessary in case of lack of surgical radicality. In this article, we described our experience and a review of the literature, with a particular focus on radiation-induced toxicity and on the feasibility of re-irradiation. A 70-year-old patient with EPMD underwent adjuvant radiotherapy in 2015. After 28 months for recurrence another radiant treatment was performed. No G3 (CTCAE v4) toxicity were recorded. In the last follow-up visit at 18 months, no signs of relapse were reported. A search strategy of the bibliographic database PubMed was performed. The inclusion criteria for the articles were case report, clinical prospective, or retrospective studies with histological confirmation of EMPD of scrotum and penis; studies with patients undergoing RT; studies in the past 30 years. In most of the 14 reported studies, RT was overall well tolerated. The major observed toxicity was G3 skin toxicity in one study. To our knowledge, there are no other cases of EPMD re-irradiation in literature. Our patient showed an excellent response and tolerated very well the high doses of both the radiation treatments. This suggests that the tolerance of skin to re-irradiation following a long period between the two treatments may be comparable to the normal constraints.
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13890Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Kanitakis J. Mammary and extramammary Paget's disease. J Eur Acad Dermatol Venereol. 2007;21:581-590. https://doi.org/10.1111/j.1468-3083.2007.02154.x.
Shepherd V, Davidson EJ, Davies-Humphreys J. Extramammary Paget's disease. BJOG. 2005;112:273-279. https://doi.org/10.1111/j.1471-0528.2004.00438.x.
Zollo JD, Zeitouni NC. The Roswell Park Cancer Institute experience with extramammary Paget's disease. Br J Dermatol. 2000;142:59-65. https://doi.org/10.1046/j.1365-2133.2000.03242.x.
Simonds RM, Segal RJ, Sharma A. Extramammary Paget's disease: a review of the literature. Int J Dermatol. 2019;58:871-879. https://doi.org/10.1111/ijd.14328.
Lloyd J, Flanagan AM. Mammary and extramammary Paget's disease. J Clin Pathol. 2000;53:742-749. https://doi.org/10.1136/jcp.53.10.742.
McCarter MD, Quan SHQ, Busam K, Paty PP, Wong D, Guillem JG. Long-term outcome of perianal Paget's disease. Dis Colon Rectum. 2003;46:612-616. https://doi.org/10.1007/s10350-004-6618-x.
Perez DR, Trakarnsanga A, Shia J, et al. Management and outcome of perianal Paget's disease: a six-decade institutional experience. Dis Colon Rectum. 2014;57:747-751. https://doi.org/10.1097/DCR.0000000000000100.
Ogawa T, Nagashima Y, Wada H, et al. Extramammary Paget's disease: analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein. Hum Pathol. 2005;36:1273-1280. https://doi.org/10.1016/j.humpath.2005.09.009.
van der Zwan JM, Siesling S, Blokx WAM, JPEN P, Capocaccia R. Invasive extramammary Paget's disease and the risk for secondary tumours in Europe. Eur J Surg Oncol. 2012;38:214-221. https://doi.org/10.1016/j.ejso.2011.12.008.
Ito Y, Igawa S, Ohishi Y, Uehara J, Yamamoto AI, Iizuka H. Prognostic indicators in 35 patients with extramammary Paget's disease. Dermatol Surg. 2012;38:1938-1944. https://doi.org/10.1111/j.1524-4725.2012.02584.x.
Lam C, Funaro D. Extramammary Paget's disease: summary of current knowledge. Dermatol Clin. 2010;28:807-826. https://doi.org/10.1016/j.det.2010.08.002.
Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989;244:707-712. https://doi.org/10.1126/science.2470152.
Moretto P, Nair VJ, Hallani SE, et al. Management of penoscrotal extramammary Paget disease: case series and review of the literature. Curr Oncol. 2013;20:e311-e320. https://doi.org/10.3747/co.20.1353.
Hata M, Koike I, Wada H, et al. Postoperative radiation therapy for extramammary Paget's disease. Br J Dermatol. 2015;172:1014-1020. https://doi.org/10.1111/bjd.13357.
Hata M, Koike I, Minagawa Y, et al. Radiation therapy for extramammary Paget disease: treatment outcomes and prognostic factors. Int J Radiat Oncol Biol Phys. 2013;87:S613. https://doi.org/10.1016/j.ijrobp.2013.06.1622.
Hata M, Omura M, Koike I, et al. Role of radiotherapy as curative treatment of extramammary Paget's disease. Int J Radiat Oncol Biol Phys. 2011;80:47-54. https://doi.org/10.1016/j.ijrobp.2010.01.073.
Hata M, Koike I, Wada H, et al. Definitive radiation therapy for extramammary Paget's disease. Anticancer Res. 2012;32:3315-3320. https://doi.org/10.1111/bjd.13357.
Hata M, Koike I, Wada H, et al. Radiation therapy for lymph node metastasis from extramammary Paget's disease. J Eur Acad Dermatol Venereol. 2014;28:873-877. https://doi.org/10.1111/jdv.12185.
Brierley JD, Stockdale AD. Radiotherapy: an effective treatment for extramammary Paget's disease. Clin Oncol. 1991;3:3-5. https://doi.org/10.1016/S0936-6555(05)81030-1.
Besa P, Rich TA, Delclos L, Edwards CL, Ota DM, Wharton JT. Extramammary Paget's disease of the perineal skin: role of radiotherapy. Int J Radiat Oncol Biol Phys. 1992;24:73-78. https://doi.org/10.1016/0360-3016(92)91024-h.
Burrows NP, Jones DH, Hudson PM, Pye RJ. Treatment of extramammary Paget's disease by radiotherapy. Br J Dermatol. 1995;132:970-972. https://doi.org/10.1111/j.1365-2133.1995.tb16957.x.
Moreno-Arias GA, Conill C, Castells-Mas A, Arenas M, Grimalt R. Radiotherapy for genital extramammary Paget's disease in situ. Dermatol Surg. 2001;27:587-590. https://doi.org/10.1046/j.1524-4725.2001.00304.x.
Luk NM, Yu KH, Yeung WK, Choi CL, Teo ML. Extramammary Paget's disease: outcome of radiotherapy with curative intent. Clin Exp Dermatol. 2003;28:360-363. https://doi.org/10.1046/j.1365-2230.2003.01301.x.
Itonaga T, Nakayama H, Okubo M, et al. Radiotherapy in patients with extramammary Paget's disease: our own experience and review of the literature. Oncol Res Treat. 2014;37:18-22. https://doi.org/10.1159/000358161.
Tackenberg S, Gehrig A, Dummer R, Navarini AA. External beam radiotherapy of extramammary Paget disease. Cutis. 2015;95:109-112.
Mammino JR, Daze RP, Mammino J. Fungal masquerader: a case report of extramammary Paget's disease treated with radiotherapy. Cureus. 2019;11:e5937. https://doi.org/10.7759/cureus.5937.
Kim TH, Chang IH, Kim T-H, Lee SY, Myung SC. Extramammary Paget's disease of scrotum treated with radiotherapy. Urology. 2009;74:474.e1-474.e3. https://doi.org/10.1016/j.urology.2008.04.018.
Karam A, Dorigo O. Treatment outcomes in a large cohort of patients with invasive extramammary Paget's disease. Gynecol Oncol. 2012;125:125-351. https://doi.org/10.1016/j.ygyno.2012.01.032.
Qi Y, Hu J, Sun C, Zhang J, Liu Q. Extramammary Paget's disease: analysis of 17 Chinese cases. Indian J Dermatol Venereol Leprol. 2014;80:129-133. https://doi.org/10.4103/0378-6323.129385.
Zhang N, Gong K, Zhang X, Yang Y, Na Y. Extramammary Paget's disease of scrotum: report of 25 cases and literature review. Urol Oncol. 2010;28:28-33. https://doi.org/10.1016/j.urolonc.2008.07.002.
Hoch WH. Adenocarcinoma of the scrotum (extramammary Paget's disease): case report and review of the literature. J Urol. 1984;132:137-139. https://doi.org/10.1016/s0022-5347(17)49501-2.
Tagliaferri L, Casà C, Macchia G, et al. The role of radiotherapy in extramammary Paget disease: a systematic review. Int J Gynecol Cancer. 2018;28:829-839. https://doi.org/10.1097/IGC.0000000000001237.
Hunter RD, Stewart JG. The tolerance of re-irradiation of heavily irradiated human skin. Br J Radiol. 1977;50:573-575. https://doi.org/10.1259/0007-1285-50-596-573.
Nieder C, Langendijk JA, Guckenberger M, Grosu AL. Second re-irradiation: a narrative review of the available clinical data. Acta Oncol. 2018;57:305-310. https://doi.org/10.1080/0284186X.2017.1409433.
Dionisi F, Fiorica F, D'Angelo E, et al. Organs at risk's tolerance and dose limits for head and neck cancer re-irradiation: a literature review. Oral Oncol. 2019;98:35-47. https://doi.org/10.1016/j.oraloncology.2019.08.017.
Muirhead, R, Jones, B. Re-irradiation is now a real option: but how do we take it forward? Clin Oncol 2018;30(2):P65-P66. https://www.clinicaloncologyonline.net/article/S0936-6555(17)30489-2/abstract.
Nieder C. Second re-irradiation: a delicate balance between safety and efficacy. Phys Med. 2019;58:155-158. https://doi.org/10.1016/j.ejmp.2019.01.004.
Caravatta L, Fiorica F, Rosa C, et al. Role of upper abdominal reirradiation for gastrointestinal malignancies: a systematic review of cumulative dose, toxicity, and outcomes on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Strahlenther Onkol. 2020;196:1-14. https://doi.org/10.1007/s00066-019-01519-5.
Janssen S, Rades D, Meyer A, et al. Local recurrence of breast cancer: conventionally fractionated partial external beam re-irradiation with curative intention. Strahlenther Onkol. 2018;194:806-814. https://doi.org/10.1007/s00066-018-1315-1.
Cosset J-M, Chargari C, Créhange G. Réirradiations: quels critères décisionnels? Cancer/Radiothérapie. 2019;23:526-530. https://doi.org/10.1016/j.canrad.2019.06.007.
Dörr W, Gabryś D. The principles and practice of re-irradiation in clinical oncology: an overview. Clin Oncol. 2018;30:67-72. https://doi.org/10.1016/j.clon.2017.11.014.
Ginot A, Doyen J, Hannoun-Lévi J-M, Courdi A. Dose de tolérance des tissus sains: la peau et les phanères. Cancer/Radiothérapie. 2010;14:379-385. https://doi.org/10.1016/j.canrad.2010.03.015.